These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3162850)

  • 1. Phase II trial of idarubicin in patients with advanced lymphoma.
    Gillies H; Liang R; Rogers H; Harper P; Parapia L; Cox G; Johnson S
    Cancer Chemother Pharmacol; 1988; 21(3):261-4. PubMed ID: 3162850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of idarubicin in advanced cervical carcinoma.
    Hakes TB; Dougherty JB; Raymond V
    Am J Clin Oncol; 1986 Jun; 9(3):262-3. PubMed ID: 3460321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
    Bastholt L; Dalmark M
    Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
    Chisesi T; Capnist G; de Dominicis E; Dini E
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):681-4. PubMed ID: 3164269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A phase I trial of idarubicin by oral administration].
    Ogawa M; Kimura K; Taguchi T; Wakui A; Hattori M; Shimoyama T; Fujita H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1896-900. PubMed ID: 3473981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anthracycline analogs in advanced breast cancer.
    Bonfante V; Ferrari L; Brambilla C; Rossi A; Villani F; Crippa F; Valagussa P; Bonadonna G
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1379-85. PubMed ID: 3470179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
    Wander HE; Meyer D; Schuff-Werner P; Nagel GA
    Onkologie; 1986 Aug; 9(4):236-8. PubMed ID: 3531951
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.
    Smith DB; Howell A
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):391-4. PubMed ID: 3475204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of idarubicin administered i.v. to pediatric patients with acute lymphoblastic leukemia.
    Madon E; Grazia G; De Bernardi B; Comelli A; Carli M; Sainati L; Paolucci G; Canino R; Colella R; Bagnulo S
    Cancer Treat Rep; 1987 Sep; 71(9):855-6. PubMed ID: 3476202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial with oral idarubicin in advanced breast cancer.
    Lopez M; Di Lauro L; Papaldo P; Lazzaro B; Ganzina F; Di Pietro N
    Invest New Drugs; 1986; 4(1):39-42. PubMed ID: 3457780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
    Toffoli G; Sorio R; Aita P; Crivellari D; Corona G; Bearz A; Robieux I; Colussi AM; Stocco F; Boiocchi M
    Clin Cancer Res; 2000 Jun; 6(6):2279-87. PubMed ID: 10873078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of idarubicin in advanced endometrial carcinoma.
    Hakes TB; Raymond V
    Cancer Treat Rep; 1987 May; 71(5):535-6. PubMed ID: 3471330
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
    Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
    Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
    Hurteloup P; Ganzina F
    Drugs Exp Clin Res; 1986; 12(1-3):233-46. PubMed ID: 3525075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
    Stuart NS; Cullen MH; Priestman TJ; Blackledge GR; Tyrrell CJ
    Cancer Chemother Pharmacol; 1988; 21(4):351-4. PubMed ID: 3163529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial.
    Hochster HS; Green MD; Blum RH; Wernz JC; Speyer JL; Muggia FM
    Invest New Drugs; 1986; 4(3):275-8. PubMed ID: 3469171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.
    Tan CT; Hancock C; Steinherz P; Bacha DM; Steinherz L; Luks E; Winick N; Meyers P; Mondora A; Dantis E
    Cancer Res; 1987 Jun; 47(11):2990-5. PubMed ID: 3471321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of oral idarubicin given with a weekly schedule.
    Dodion P; Finet C; Crespeigne N; Beer M; Nicaise C; Rozencweig M; Kenis Y
    Invest New Drugs; 1986; 4(1):31-8. PubMed ID: 3457779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma.
    Scher HI; Yagoda A; Ahmed T; Budman D; Sordillo P; Watson RC
    Cancer Chemother Pharmacol; 1985; 14(1):79-80. PubMed ID: 3855289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral idarubicin in non-Hodgkin's lymphomas.
    Lopez M; Di Lauro L; Papaldo P
    Invest New Drugs; 1986; 4(3):263-7. PubMed ID: 3469170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.